21C2 Lymphoma (Case 21) CD3 20X | Lymphoma, primary | NEOPLASMS (HEMATOLYMPHOID)

Washington University Experience | NEOPLASMS (HEMATOLYMPHOID) | Lymphoma, primary | 21C2 Lymphoma (Case 21) CD3 20X

Reactivity for T-lymphocyte marker CD3 stains only the population of small, non-neoplastic lymphocytes.